DNA Damage Repair Pathways Play a Critical Role in Myeloid Differentiation
DNA 损伤修复途径在骨髓分化中发挥关键作用
基本信息
- 批准号:10683704
- 负责人:
- 金额:$ 3.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Lung InjuryAcute Respiratory Distress SyndromeAdaptive Immune SystemAffectAlveolarBase Excision RepairsBiological AssayBronchoalveolar Lavage FluidCell Differentiation processCell SeparationCell physiologyCell surfaceCellsChronic Obstructive Pulmonary DiseaseCytokine SignalingCytoprotectionDNA AdductionDNA AdductsDNA DamageDNA RepairDNA Repair DisorderDNA Repair PathwayDNA Sequence AlterationDNA analysisDNA lesionDataDefectDendritic CellsDendritic cell activationEffector CellExcision RepairExhibitsExposure toFoundationsGene Expression ProfilingGoalsHematopoiesisHistologyHumanImmuneImmune System DiseasesImmune responseIn VitroIndividualIndividual DifferencesInfectionInfiltrationInflammationInflammatoryInflammatory ResponseInhalationInnate Immune ResponseInnate Immune SystemKnockout MiceKnowledgeLeadLinkLungLung AdenomaLung diseasesMacrophageMaintenanceMeasurementMeasuresMediatingMusMyelogenousMyeloid Cell ActivationMyeloid Progenitor CellsNatural Killer CellsNonhomologous DNA End JoiningNucleotide Excision RepairPathway interactionsPatientsPhenotypePlayPoly I-CPopulationPredispositionPrevalenceReactive Oxygen SpeciesRegulationResearchRoleSignal TransductionStimulusStructure of parenchyma of lungT-Cell ActivationT-LymphocyteTestingTrichothiodystrophyUV inducedUp-RegulationWorkXeroderma Pigmentosumadaptive immune responsecancer therapycell typecytokineexperiencegene repairgenome integrityimmune activationimmune functionimmunogenicin vivoinnate immune functioninsightmonocytenoveloxidative damagepreventrepairedresponsetoxicantultraviolet damage
项目摘要
PROJECT SUMMARY
Differentiation of myeloid progenitor cells produces a wide variety of downstream effector cells that are
integral components of the innate immune system. During hematopoiesis, monocytes are produced as
surveillance units, waiting to receive signals from cytokines identifying regions of inflammation or infection.
Induction of differentiation may produce dendritic cells or macrophages, dependent on the signals received,
and inflammatory conditions are associated with the release of DNA damaging agents that could potentially
impact the function of immune cells. But the mechanisms involved in protecting the differentiated effector
cells from DNA damage is relatively under-investigated, particularly for dendritic cells. Therefore, in this
proposal we investigate how DNA damage and repair affect the differentiation and activation of dendritic
cells. Our preliminary data indicate a major deficiency in the nucleotide excision repair (NER) pathway in
dendritic cells, whereas other pathways, including non-homologous end joining and base excision repair
remain proficient. Since these pathways specialize in the repair of different types of DNA damage, these
data suggest that dendritic cells may be more sensitive to some DNA damaging agents than others. The
goals of this proposal are to determine the role of DNA repair during the differentiation and activation of
dendritic cells and to determine the effect of dysregulation of the NER pathway on the ability to mount an
inflammatory response in the lung. I hypothesize that DNA repair plays a critical role in the differentiation
and the function of dendritic cells and that dysregulation of DNA repair diminishes the ability of dendritic cells
to activate T cells. In order to study this, I will first determine the effect of DNA damage on the differentiation
and activation of dendritic cells. By first isolating human monocytes and then challenging them with a panel
of DNA damaging agents during differentiation, I will determine how specific types of DNA damage affect the
differentiation of dendritic cells and their ability of to activate T cells in vitro. To determine how inefficient
DNA repair affects dendritic cell differentiation and function in vivo, I will investigate the ability of mice
deficient in the NER gene, XPC, to induce an inflammatory response after exposure to the immunogenic
agent poly(I:C). Analysis of cytokines and cell infiltrates into the bronchoalveolar lavage fluid and intact lung
tissue will be utilized in order to determine the change in dendritic cell and T cell activation compared to WT
controls. Completion of this project will yield new insights into the roles of DNA damage and repair in
dendritic cell differentiation and function, and will provide a foundation for understanding and possibly
controlling immune responses in patients, particularly under conditions that promote DNA damage including
cancer therapy, inflammation, and inhaled toxicants.
项目摘要
髓系祖细胞的分化产生多种下游效应细胞,
先天免疫系统的组成部分。在造血过程中,单核细胞作为
监视单元,等待接收来自细胞因子的信号,以识别炎症或感染区域。
分化的诱导可以产生树突细胞或巨噬细胞,这取决于所接收的信号,
炎症与DNA损伤剂的释放有关,
影响免疫细胞的功能。但是保护分化的效应物的机制
细胞免受DNA损伤的研究相对不足,特别是树突状细胞。所以在这
我们研究DNA损伤和修复如何影响树突状细胞的分化和激活,
细胞我们的初步数据表明,一个主要的缺陷,在核苷酸切除修复(NER)途径,
而其他途径,包括非同源末端连接和碱基切除修复
保持熟练。由于这些途径专门修复不同类型的DNA损伤,
数据提示树突细胞可能对某些DNA损伤剂比其它的更敏感。的
该提案的目标是确定DNA修复在细胞分化和激活过程中的作用,
树突状细胞,并确定NER途径的失调对树突状细胞的能力的影响。
肺部的炎症反应我假设DNA修复在分化中起着关键作用,
和树突状细胞的功能,以及DNA修复的失调降低了树突状细胞的能力,
来激活T细胞为了研究这一点,我将首先确定DNA损伤对分化的影响,
和树突状细胞的激活。通过首先分离人单核细胞,然后用一个面板挑战它们,
DNA损伤剂在分化过程中,我将确定如何特定类型的DNA损伤影响,
树突状细胞的分化及其体外活化T细胞的能力。为了确定
DNA修复影响树突状细胞的分化和功能在体内,我将调查小鼠的能力
NER基因XPC缺陷,以在暴露于免疫原性
试剂poly(I:C)。支气管肺泡灌洗液和完整肺中细胞因子和细胞浸润的分析
将使用组织以确定与WT相比树突状细胞和T细胞活化的变化
对照该项目的完成将对DNA损伤和修复的作用产生新的见解,
树突状细胞的分化和功能,并将提供一个基础,了解和可能
控制患者的免疫反应,特别是在促进DNA损伤的条件下,
癌症治疗、炎症和吸入毒物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Turner John Pecen其他文献
Turner John Pecen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Turner John Pecen', 18)}}的其他基金
DNA Damage Repair Pathways Play a Critical Role in Myeloid Differentiation
DNA 损伤修复途径在骨髓分化中发挥关键作用
- 批准号:
10312359 - 财政年份:2021
- 资助金额:
$ 3.37万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 3.37万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别: